IPOs this week : Aug 12 - 16, 19 (wk 33)

IPOs expected to price during the week include:

• BioVie (OTCQB:BIVI) on August 12 and 
• CrossFirst Bankshares (CFB) on August 14:  Kansas corporation and registered bank holding company with total assets of $4.5 bln [Planning to offer 7.11 mln shares between $15.00-17.00]

9F (NYSE: JFU): Leading digital financial account platform integrating and personalizing financial services in China [Planning to offer 8.9 mln ADS between $7.50-9.50]

WiMi Hologram Cloud (Nasdaq: WIMI): Provider of augmented reality-based holographic services and products [Planning to offer 4 mln shares between $7.50-9.50]

IPO quiet period expirations

• Phreesia (NYSE:PHR), DouYu (NASDAQ:DOYU), Owl Rock Capital (NYSE:ORCC), Mirum Pharmaceuticals (NASDAQ:MIRM), Fulcrum Therapeutics (NASDAQ:FULC), Genmab (NASDAQ:GMAB), Assetmark Financial (NYSE:AMK) and First Seacoast Bancorp (FSEA) on August 12
• Medallia (NYSE:MDLA), Afya (NASDAQ:AFYA) and Intercorp Financial (IFS) on August 13. 

IPO lockup expirations

• There are also IPO expirations for TCR2 Therapeutics (NASDAQ:TCRR), Intercorp Financial (IFS) and Avedro (NASDAQ:AVDR) on August 13.

Avedro (AVDR) began trading on the Nasdaq on 14 February 2019

Avedro, Inc., an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness.

• Sector: Healthcare
• Industry: Medical Devices
• HQ: Waltham, Massachusetts
• http://avedro.com

IPOs this week : March 11 - 15, 2019

IPO activity: The six-month lockup on shares of Nio (NYSE:NIO) expires on March 11 in what should be a good test of investor sentiment. Nio soared following a positive 60 Minutes piece about two weeks ago before going into post-earnings skid. Interestingly, Goldman Sachs came in with a reinstated Buy call on Nio ahead of the lockup expiration as it pointed to the Chinese automaker's "successful branding" in the premium segment.

Other lockup expirations this week include;

• 111 (NASDAQ:YI) on March 11, 
• FVC Bancorp (NASDAQ:FVCB) on March 12 and 
• both Principia Biopharma (NASDAQ:PRNB) and Qutoutiao (NASDAQ:QTT) on March 13. 

Analysts can start covering TCR2 Therapeutics (NASDAQ:TCRR), Avedro (NASDAQ:AVDR), Achiano Therapeutics (NASDAQ:ANCN) and Imac (NASDAQ:IMAC) on March 11 and Stealth BioTherapeutics (NASDAQ:MITO) on March 12.

IPOs this week : Feb. 11 - 15, 2019

IPOs expected to price:

• Anchiano Therapeutics (ANCN) on February 11; 
• Virgin Trains USA (VTUS) on February 12; 
• TCR2 Therapeutics (TCRR), 
• Cibus (CBUS) and Avedro (AVDR) on February 13; 
• Stealth BioTherapeutics (MITO) on February 14.

IPO activity: In case you missed it, the IPO market was lit up with the news that Postmates (POSTM) and Slack (SLACK) filed for confidential listings.

There are IPO share lock-up expirations upcoming on Avalon GloboCare (OTCQB:AVCO) and Aridis Pharmaceuticals (NASDAQ:ARDS) on February 12 and Safe-T (NASDAQ:SFET) on February 13.